KAPA insider transactions
Kairos Pharma Ltd. (KAPA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for KAPA
- Chief Scientific Officer Bhowmick Neil was granted 171,756 shares, increasing direct ownership by 15% to 1,311,739 units (SEC Form 4)4 - Kairos Pharma, LTD. (0001962011) (Issuer)
- Director Bae Hyun W. was granted 29,084 shares, increasing direct ownership by 66% to 73,370 units (SEC Form 4)4 - Kairos Pharma, LTD. (0001962011) (Issuer)
- VP of Research and Development Murali Ramachandran was granted 152,672 shares, increasing direct ownership by 104% to 299,529 units (SEC Form 4)4 - Kairos Pharma, LTD. (0001962011) (Issuer)
- Director Keyoung Hansoo Michael was granted 29,084 shares (SEC Form 4)4 - Kairos Pharma, LTD. (0001962011) (Issuer)
- Director Singhvi Rahul was granted 19,084 shares, increasing direct ownership by 63% to 49,204 units (SEC Form 4)4 - Kairos Pharma, LTD. (0001962011) (Issuer)
- CEO and Chairman Yu John S was granted 190,840 shares, increasing direct ownership by 486% to 230,105 units (SEC Form 4)4 - Kairos Pharma, LTD. (0001962011) (Issuer)
- Chief Financial Officer Samuelson Doug was granted 152,672 shares, increasing direct ownership by 109% to 293,039 units (SEC Form 4)4 - Kairos Pharma, LTD. (0001962011) (Issuer)
- New insider Singhvi Rahul claimed ownership of 30,120 shares (SEC Form 3)3 - Kairos Pharma, LTD. (0001962011) (Issuer)
- Chief Scientific Officer Bhowmick Neil was granted 14,000 shares, increasing direct ownership by 1% to 1,139,983 units (SEC Form 4)4 - Kairos Pharma, LTD. (0001962011) (Issuer)
- VP of Research and Development Murali Ramachandran was granted 14,000 shares, increasing direct ownership by 11% to 147,057 units (SEC Form 4)4 - Kairos Pharma, LTD. (0001962011) (Issuer)
- CEO and Chairman Yu John S was granted 14,000 shares, increasing direct ownership by 0.26% to 5,355,838 units (SEC Form 4)4 - Kairos Pharma, LTD. (0001962011) (Issuer)
- VP of Research and Development Murali Ramachandran bought $318 worth of shares (200 units at $1.59), increasing direct ownership by 0.15% to 133,057 units (SEC Form 4)4 - Kairos Pharma, LTD. (0001962011) (Issuer)
- Chief Financial Officer Samuelson Doug bought $3,750 worth of shares (2,500 units at $1.50), increasing direct ownership by 4% to 60,796 units (SEC Form 4)4 - Kairos Pharma, LTD. (0001962011) (Issuer)
- CEO and Chairman Yu John S bought $5,760 worth of shares (4,000 units at $1.44), increasing direct ownership by 0.07% to 5,341,837 units (SEC Form 4)4 - Kairos Pharma, LTD. (0001962011) (Issuer)
- New insider Keyoung Hansoo Michael claimed no ownership of stock in the company (SEC Form 3)3 - Kairos Pharma, LTD. (0001962011) (Issuer)
- New insider Yu John S claimed ownership of 5,337,837 shares (SEC Form 3)3 - Kairos Pharma, LTD. (0001962011) (Issuer)
- New insider Samuelson Doug claimed ownership of 58,296 shares (SEC Form 3)3 - Kairos Pharma, LTD. (0001962011) (Issuer)
- New insider Murali Ramachandran claimed ownership of 132,857 shares (SEC Form 3)3 - Kairos Pharma, LTD. (0001962011) (Issuer)
- New insider Bhowmick Neil claimed ownership of 1,125,983 shares (SEC Form 3)3 - Kairos Pharma, LTD. (0001962011) (Issuer)
- New insider Mazanet Rosemary claimed no ownership of stock in the company (SEC Form 3)3 - Kairos Pharma, LTD. (0001962011) (Issuer)
- New insider Bae Hyun W. claimed ownership of 44,286 shares (SEC Form 3)3 - Kairos Pharma, LTD. (0001962011) (Issuer)